Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
Recruiting
Observational Study
ALL, Childhood
Pediatric Cancer
Toxicity, Drug
Adverse Drug Event
Relapse Leukemia
Drug Toxicity
Drug Effect
Drug Interaction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 1 – 18
- Sex
- Any
- Study type
- Observational
- Participants needed
- 556 (estimated)
- Sponsor
- University of Geneva, Switzerland · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A five-year prospective observational cohort study. The study is focused on observing the relation between static germline variants and therapeutic response in Indian children with acute lymphoblastic leukemia (ALL). The project is an International multicenter setup. This collaborative research project between Switzerland and India includes one main center in Geneva that has conceptualized, design…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age \> 1 year old and ≤18 years old at enrolment
* Previously untreated
* ALL diagnosis confirmed by morphology and flow-cytometry
* Indian origins
* Fulfilling IciCle treatment protocol inclusion criteria and receiving treatment as per the protocol
* Written Informed consent …
Contacts